|
SFRS18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.80189999998692E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.576000E-04 |
| Normal-vs-Stage2 |
2.2779999999667E-06 |
| Normal-vs-Stage3 |
4.58929999558322E-08 |
| Normal-vs-Stage4 |
1.819410E-03 |
| Stage1-vs-Stage2 |
3.180400E-02 |
| Stage1-vs-Stage3 |
7.876800E-03 |
| Stage1-vs-Stage4 |
4.821200E-01 |
| Stage2-vs-Stage3 |
8.307600E-01 |
| Stage2-vs-Stage4 |
2.781200E-01 |
| Stage3-vs-Stage4 |
3.017400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56649999999425E-05 |
| Normal-vs-AfricanAmerican |
5.460700E-03 |
| Normal-vs-Asian |
1.043590E-01 |
| Caucasian-vs-AfricanAmerican |
9.639600E-01 |
| Caucasian-vs-Asian |
2.820500E-02 |
| AfricanAmerican-vs-Asian |
1.492150E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.156100E-04 |
| Normal-vs-Female |
1.32190000001753E-06 |
| Male-vs-Female |
5.891200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.366800E-04 |
| Normal-vs-Age(41-60Yrs) |
3.79500000000643E-05 |
| Normal-vs-Age(61-80Yrs) |
1.50720000002824E-06 |
| Normal-vs-Age(81-100Yrs) |
9.74869999947892E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.188600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.665900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.221600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.711570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.404200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.276000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.2978999999923E-05 |
| Classical-VS-Follicular |
2.645400E-01 |
| Classical-VS-Other |
4.826600E-01 |
| Classical-VS-Normal |
9.84039999999409E-05 |
| Tall-VS-Follicular |
1.184010E-02 |
| Tall-VS-Other |
7.441700E-02 |
| Tall-VS-Normal |
3.75810005337485E-09 |
| Follicular-VS-Other |
3.508000E-01 |
| Follicular-VS-Normal |
1.973420E-04 |
| Other-VS-Normal |
3.975200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.0464999999904E-06 |
| Normal-vs-N1 |
2.250200E-01 |
| N0-vs-N1 |
3.305900E-02 |
|
|
